India Expects U.S.-Indian Ties Under Freer Embryonic Stem Cell Policy
This article was originally published in PharmAsia News
Executive Summary
Indian research organizations expect to reap the benefits of the U.S. change in policy to free up federal funds for research using embryonic stem cells. The Indian organizations expect foreign research firms to seek collaboration with Indian companies to conduct the research because of the country's cheaper research and trial costs. India's policy on embryonic stem cell research is close to the new U.S. policy and the genetic versatility of its huge population also is highly attractive. Stem cell research in general is expected to grow about 15 percent in India by 2010. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.